Skip to main content
BusinessResearch

Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials

Source: TechCrunch (opens in a new tab) · Ram Iyer

Intel Summary

TechCrunch reports that AI drug-discovery company Isomorphic Labs, spun out of Google's DeepMind in 2021, has raised $5 billion in a Series C funding round to advance its AI-designed drug candidates into clinical trials.

Why It Matters

A multi-billion-dollar financing round underscores institutional momentum behind AI-driven pharmacology moving past computational discovery and into formal human clinical testing, serving as a high-stakes test for AI computational models in therapeutic pipeline development.

Organizations & Entities